Literature DB >> 32868295

Receptor-independent modulation of cAMP-dependent protein kinase and protein phosphatase signaling in cardiac myocytes by oxidizing agents.

Simon Diering1, Konstantina Stathopoulou1, Mara Goetz1, Laura Rathjens1, Sönke Harder2, Angelika Piasecki1, Janice Raabe1, Steven Schulz1, Mona Brandt1, Julia Pflaumenbaum1, Ulrike Fuchs1, Sonia Donzelli1, Sakthivel Sadayappan3, Viacheslav O Nikolaev4, Frederik Flenner1, Elisabeth Ehler5, Friederike Cuello6.   

Abstract

The contraction and relaxation of the heart is controlled by stimulation of the β1-adrenoreceptor (AR) signaling cascade, which leads to activation of cAMP-dependent protein kinase (PKA) and subsequent cardiac protein phosphorylation. Phosphorylation is counteracted by the main cardiac protein phosphatases, PP2A and PP1. Both kinase and phosphatases are sensitive to intramolecular disulfide formation in their catalytic subunits that inhibits their activity. Additionally, intermolecular disulfide formation between PKA type I regulatory subunits (PKA-RI) has been described to enhance PKA's affinity for protein kinase A anchoring proteins, which alters its subcellular distribution. Nitroxyl donors have been shown to affect contractility and relaxation, but the mechanistic basis for this effect is unclear. The present study investigates the impact of several nitroxyl donors and the thiol-oxidizing agent diamide on cardiac myocyte protein phosphorylation and oxidation. Although all tested compounds equally induced intermolecular disulfide formation in PKA-RI, only 1-nitrosocyclohexalycetate (NCA) and diamide induced reproducible protein phosphorylation. Phosphorylation occurred independently of β1-AR activation, but was abolished after pharmacological PKA inhibition and thus potentially attributable to increased PKA activity. NCA treatment of cardiac myocytes induced translocation of PKA and phosphatases to the myofilament compartment as shown by fractionation, immunofluorescence, and proximity ligation assays. Assessment of kinase and phosphatase activity within the myofilament fraction of cardiac myocytes after exposure to NCA revealed activation of PKA and inhibition of phosphatase activity thus explaining the increase in phosphorylation. The data suggest that the NCA-mediated effect on cardiac myocyte protein phosphorylation orchestrates alterations in the kinase/phosphatase balance.
© 2020 Diering et al.

Entities:  

Keywords:  cardiac myocyte; cardiomyocyte; cardiovascular disease; kinase; nitroxyl; oxidation; phosphatase; phosphorylation; protein kinase A (PKA); redox regulation

Mesh:

Substances:

Year:  2020        PMID: 32868295      PMCID: PMC7650233          DOI: 10.1074/jbc.RA120.014467

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

Review 1.  Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design.

Authors:  Susan S Taylor; Choel Kim; Cecilia Y Cheng; Simon H J Brown; Jian Wu; Natarajan Kannan
Journal:  Biochim Biophys Acta       Date:  2007-10-12

Review 2.  Cysteine-Based Redox Sensing and Its Role in Signaling by Cyclic Nucleotide-Dependent Kinases in the Cardiovascular System.

Authors:  Friederike Cuello; Philip Eaton
Journal:  Annu Rev Physiol       Date:  2018-09-14       Impact factor: 19.318

3.  Dephosphorylation of cardiac myofibril C-protein by protein phosphatase 1 and protein phosphatase 2A.

Authors:  K K Schlender; M G Hegazy; T J Thysseril
Journal:  Biochim Biophys Acta       Date:  1987-05-18

4.  A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists.

Authors:  G Chu; J W Lester; K B Young; W Luo; J Zhai; E G Kranias
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

Review 5.  Evolving therapies for the management of chronic and acute decompensated heart failure.

Authors:  Jennifer C Cook; Richard H Tran; J Herbert Patterson; Jo E Rodgers
Journal:  Am J Health Syst Pharm       Date:  2016-11-01       Impact factor: 2.637

Review 6.  Agents with vasodilator properties in acute heart failure.

Authors:  Abhishek Singh; Saïd Laribi; John R Teerlink; Alexandre Mebazaa
Journal:  Eur Heart J       Date:  2017-02-01       Impact factor: 29.983

7.  Reversible inhibition of the protein phosphatase 1 by hydrogen peroxide. Potential regulation of eIF2 alpha phosphorylation in differentiated PC12 cells.

Authors:  A O'Loghlen; M I Pérez-Morgado; M Salinas; M E Martín
Journal:  Arch Biochem Biophys       Date:  2003-09-15       Impact factor: 4.013

8.  Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function.

Authors:  Robert S Haworth; Friederike Cuello; Todd J Herron; Gereon Franzen; Jonathan C Kentish; Mathias Gautel; Metin Avkiran
Journal:  Circ Res       Date:  2004-10-28       Impact factor: 17.367

9.  Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution.

Authors:  Xiaoke Yin; Friederike Cuello; Ursula Mayr; Zhiqi Hao; Martin Hornshaw; Elisabeth Ehler; Metin Avkiran; Manuel Mayr
Journal:  Mol Cell Proteomics       Date:  2009-12-27       Impact factor: 5.911

10.  2016 update of the PRIDE database and its related tools.

Authors:  Juan Antonio Vizcaíno; Attila Csordas; Noemi del-Toro; José A Dianes; Johannes Griss; Ilias Lavidas; Gerhard Mayer; Yasset Perez-Riverol; Florian Reisinger; Tobias Ternent; Qing-Wei Xu; Rui Wang; Henning Hermjakob
Journal:  Nucleic Acids Res       Date:  2015-11-02       Impact factor: 16.971

View more
  1 in total

Review 1.  Regulation of Cardiac PKA Signaling by cAMP and Oxidants.

Authors:  Friederike Cuello; Friedrich W Herberg; Konstantina Stathopoulou; Philipp Henning; Simon Diering
Journal:  Antioxidants (Basel)       Date:  2021-04-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.